Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep
Open accessAbstract
As part of the extracellular matrix (ECM), perineuronal nets (PNs) are polyanionic, chondroitin sulfate proteoglycan (CSPG)-rich coatings of certain neurons, known to be affected in various neural diseases. Although these structures are considered as important parts of the neurovascular unit (NVU), their role during evolution of acute ischemic stroke and subsequent tissue damage is poorly understoodAnd only a few preclinical studies analyzed PNs after acute ischemic stroke. By employing three models of experimental focal cerebral ischemia, this study was focused on histopathological alterations of PNs and concomitant vascular, glial and neuronal changes according to the NVU concept. We analyzed brain tissues obtained one day after ischemia onset from a) mice after filament-based permanent middle cerebral artery occlusion, b) rats subjected to thromboembolic middle cerebral artery occlusion and c) sheep at 14 days after electrosurgically induced focal cerebral ischemia. Multiple fluorescence labeling was applied to explore simultaneous alterations of NVU and ECM. Serial mouse sections labeled with the net marker Wisteria floribunda agglutinin (WFA) displayed largely decomposed and nearly erased PNs in infarcted neocortical areas that were demarcated by up-regulated immunoreactivity for vascular collagen IV. Subsequent semi-quantitative analyses in mice confirmed significantly decreased WFA-staining at the ischemic border zone and a relative decrease in the directly ischemia-affected neocortex. Triple fluorescence labeling throughout the three animal models revealed up-regulatedcollagen IV and decomposed PNs accompanied by activated astroglia and altered immunoreactivity for parvalbumin, a calcium-binding protein in fast-firing GABAergic neurons which are predominantly surrounded by neocortical PNs. Furthermore, ischemic neocortical areas in rodents simultaneously displayed less intense staining of WFA, aggrecan, the net components neurocan, versican and the cartilage link protein as well as markers in net-bearing neurons such as the potassium channel subunit Kv3.1b and NeuN. In summary, the consistent observations based on three different stroke models confirmed that PNs are highly sensitive constituents of the NVU along with impaired associated GABAergic neurons. These results suggest that PNs could be promising targets of future stroke treatment, and further studies should address their reorganization and plasticity in both stabilizing the acute stroke as well as supportive effects during the chronic phase of stroke.
AI snapshot
Written from the paper’s full text.
TL;DR
In three experimental focal cerebral ischemia models (mice, rats, sheep), ischemic neocortex showed up-regulated collagen IV and decomposed or erased perineuronal nets (PNs), alongside glial and neuronal changes. The authors conclude PNs are highly sensitive neurovascular unit constituents and potential future stroke-treatment targets.
Key findings
- Across mouse, rat, and sheep models, ischemic neocortical areas displayed increased collagen IV immunoreactivity and decomposed/erased WFA-stained PNs; triple labeling associated these changes with activated astroglia, microglia/macrophages, and altered parvalbumin immunoreactivity.
- In mice, semi-quantification showed significantly increased Coll IV integrated density from the second (7.1 × 10^11 ± 4.3 × 10^11) to third (13.1 × 10^11 ± 6.7 × 10^11) and fourth (24.2 × 10^11 ± 9.3 × 10^11) ROIs (each p = 0.043; Wilcoxon test, n = 5).
- WFA staining in ischemic mouse cortex decreased significantly from the first (17.7 × 10^11 ± 11.6 × 10^11) to third (9.28 × 10^11 ± 10.7 × 10^11) ROI and then increased toward the fifth (17.5 × 10^11 ± 11.4 × 10^11) ROI (each p = 0.043); direct interhemispheric WFA comparison in regions 4–8 barely missed significance (each p = 0.080).
- Ischemic rodent neocortex also showed less intense staining for aggrecan, neurocan, versican, cartilage link protein (CRTL), Kv3.1b, and NeuN, with only few or no PNs around parvalbumin-containing neurons.
Methods
- Three focal cerebral ischemia models were used: filament-based permanent middle cerebral artery occlusion (pMCAO) in n = 5 C57BL/6 mice, thromboembolic MCAO in n = 3 Wistar rats, and electrosurgically induced pMCAO in three adult sheep; rodent tissue was analyzed 1 day after ischemia and sheep tissue 14 days after ischemia.
- Multiple fluorescence labeling combined biotinylated WFA with antibodies against Coll IV, GFAP, Iba, parvalbumin, aggrecan, neurocan, versican, CRTL, Kv3.1b, and NeuN, followed by fluorescence and confocal microscopy.
- Semi-quantification was performed in mice using eight equally spaced ROIs per hemisphere across three sections, measuring integrated density in ImageJ for Coll IV and WFA, with Wilcoxon tests and p < 0.05 considered significant.
Limitations
- The paper states that sheep brains were not perfusion-fixed because of experimental constraints, and that limited rat and sheep tissue allowed only qualitative investigations in those species; semi-quantification was feasible only in mice based on n = 5.
- The paper states that experiments were limited to a single time point (24 h in rodents, 14 days in sheep), so the longitudinal course and whether changes are primary or secondary remain unclear.
- Evident from the text: rat and sheep sample sizes were very small (n = 3 each), and cross-species comparisons are complicated by different ischemia models, tissue processing, and post-ischemia intervals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 74 cited sources checked · 0 supported · 0 flagged
- Findingown data
Triple fluorescence labeling across three animal models revealed decomposed PNs.
“Triple fluorescence labeling throughout the three animal models revealed up-regulated Coll IV and decomposed PNs accompanied by activated astroglia and altered immunoreactivity for parvalbumin, a calcium-binding protein in fast-firing GABAergic neurons which are predominantly surrounded by neocortical PNs.”
Quote in the paperSubstantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
- Findingown data
Coll IV immunoreactivity on the non-affected hemisphere provided a consistent pattern with nearly equal integrated density values from medial to lateral.
“Thereby, the Coll IV-immunoreactivity on the non-affected hemisphere was found to provide a consistent pattern with nearly equal values for the integrated density from medial to lateral (gray bars in Figure 3B).”
Quote in the paperNot a substantial claim- Rests on an assumption: The contralateral hemisphere is non-affected and valid as an internal control for the ischemic hemisphere.
- Findingown data
WFA-binding sites showed a trend toward diminished relative labeling starting at the fourth ROI.
“The pattern of WFA-binding sites provided—at least starting at the fourth ROI—a trend towards a diminished relative labeling.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The medial-to-lateral increase in WFA-staining in the non-ischemic hemisphere represents the natural course in this neocortical region.
- Findingown data
Triple fluorescence labeling across three animal models revealed up-regulated collagen IV.
“Triple fluorescence labeling throughout the three animal models revealed up-regulated Coll IV and decomposed PNs accompanied by activated astroglia and altered immunoreactivity for parvalbumin, a calcium-binding protein in fast-firing GABAergic neurons which are predominantly surrounded by neocortical PNs.”
Quote in the paperSubstantial claim - Findingown data
Direct inter-hemispheric comparison per ROI barely missed statistical significance for regions 4-8 (each p = 0.080; Wilcoxon test, n = 5).
“The direct inter-hemispheric comparison on the level of each ROI, however, barely missed statistical significance (regions 4–8, each p = 0.080; Wilcoxon test, n = 5).”
Quote in the paperNot a substantial claim
- Findingown data
Triple fluorescence labeling across three animal models revealed altered parvalbumin immunoreactivity.
“Triple fluorescence labeling throughout the three animal models revealed up-regulated Coll IV and decomposed PNs accompanied by activated astroglia and altered immunoreactivity for parvalbumin, a calcium-binding protein in fast-firing GABAergic neurons which are predominantly surrounded by neocortical PNs.”
Quote in the paperSubstantial claim - Findingown data
In the non-affected hemisphere, WFA-binding sites showed an ascending increase from medial to lateral, representing the natural pattern in neocortical areas.
“Concerning WFA-binding sites, an ascending increase was observed in the non-affected hemisphere from medial to lateral (gray bars in Figure 3C), representing the natural pattern in neocortical areas.”
Quote in the paperNot a substantial claim- Rests on an assumption: The contralateral hemisphere is non-affected and valid as an internal control for the ischemic hemisphere.
- Findingown data
In rodents, ischemic neocortical areas displayed less intense staining of WFA, aggrecan, neurocan, versican, and cartilage link protein (CRTL).
“Furthermore, ischemic neocortical areas in rodents simultaneously displayed less intense staining of WFA, aggrecan, the net components neurocan, versican and the cartilage link protein (CRTL) as well as markers in net-bearing neurons such as the potassium channel subunit Kv3.1b and neuronal nuclei (NeuN).”
Quote in the paperSubstantial claim - Findingown data
In mice, one day after permanent middle cerebral artery occlusion, WFA-labeled sections displayed largely decomposed and nearly erased PNs in infarcted neocortical areas.
“Serial mouse sections labeled with the net marker Wisteria floribunda agglutinin (WFA) displayed largely decomposed and nearly erased PNs in infarcted neocortical areas that were demarcated by up-regulated immunoreactivity for vascular collagen IV (Coll IV).”
Quote in the paperSubstantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
- Findingown data
In rodents, ischemic neocortical areas displayed less intense staining of Kv3.1b and NeuN in net-bearing neurons.
“Furthermore, ischemic neocortical areas in rodents simultaneously displayed less intense staining of WFA, aggrecan, the net components neurocan, versican and the cartilage link protein (CRTL) as well as markers in net-bearing neurons such as the potassium channel subunit Kv3.1b and neuronal nuclei (NeuN).”
Quote in the paperSubstantial claim - Findingown data
Ischemia led to a significant increase of Coll IV immunoreactivity from the second to the third and fourth ROI in mice.
“In contrast, ischemia led to a significant increase of Coll IV-immunoreactivity (white bars in Figure 3B) from the second (7.1 × 1011 ± 4.3 × 1011) to the third (13.1 × 1011 ± 6.7 × 1011) and continued to the fourth (24.2 × 1011 ± 9.3 × 1011) ROI (each p = 0.043; Wilcoxon test, n = 5).”
Quote in the paperNot a substantial claim- Rests on an assumption: The contralateral hemisphere is non-affected and valid as an internal control for the ischemic hemisphere.
- Findingown data
Triple fluorescence labeling across three animal models revealed activated astroglia.
“Triple fluorescence labeling throughout the three animal models revealed up-regulated Coll IV and decomposed PNs accompanied by activated astroglia and altered immunoreactivity for parvalbumin, a calcium-binding protein in fast-firing GABAergic neurons which are predominantly surrounded by neocortical PNs.”
Quote in the paperNot a substantial claim - Findingown data
In a non-ischemic area, a representative PN shows honeycomb-like meshes ensheathing the whole perikaryon and surrounding the proximal dendrites.
“While Figure 2A shows a representative PN with honeycomb-like meshes ensheathing the whole perikaryon and surrounding the proximal dendrites in a non-ischemic area, Figure 2B presents only WFA-stainable remnants devoid of net-like structures in close vicinity to apparently increased vascular Coll IV-immunoreactivity within the ischemia-affected tissue.”
Quote in the paperNot a substantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
- Findingown data
In ischemia-affected tissue, only WFA-stainable remnants devoid of net-like structures were present in close vicinity to apparently increased vascular Coll IV immunoreactivity.
“While Figure 2A shows a representative PN with honeycomb-like meshes ensheathing the whole perikaryon and surrounding the proximal dendrites in a non-ischemic area, Figure 2B presents only WFA-stainable remnants devoid of net-like structures in close vicinity to apparently increased vascular Coll IV-immunoreactivity within the ischemia-affected tissue.”
Quote in the paperSubstantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
- Findingown data
In mice, one day after ischemia, collagen IV immunoreactivity became increasingly visible in ischemic areas including the striatum and neocortical structures.
“One day after induction of focal cerebral ischemia in mice, we observed opposite alterations for the vessel-associated Coll IV and binding sites for the PN marker WFA, while Coll IV-immunoreactivity became increasingly visible in ischemic areas including the striatum and neocortical structures.”
Quote in the paperSubstantial claim - Findingown data
In rodents, the infarcted zone was partly devoid of microglia immunoreactive for Iba.
“Remarkably, the infarcted zone of rodents was partly devoid of microglia immunoreactive for the ionized calcium-binding adaptor molecule 1 (Iba; asterisks in Figures 4A, 5A).”
Quote in the paperNot a substantial claim - Findingown data
Direct inter-hemispheric comparison revealed a significant increase of Coll IV immunoreactivity starting in the ischemic bordering zone and continuing towards the most lateral ROI.
“Consequently, direct inter-hemispheric comparison revealed a significant increase of Coll IV-immunoreactivity starting in the ischemic bordering zone and continued towards the most lateral ROI (each p = 0.043; Wilcoxon test, n = 5).”
Quote in the paperSubstantial claim- Rests on an assumption: The contralateral hemisphere is non-affected and valid as an internal control for the ischemic hemisphere.
- Findingown data
In all three models, up-regulated Coll IV immunoreactivity delineated ischemia-affected tissue.
“Analyses focusing on the spatial relationship to parvalbumin—as marker for most neocortical net-bearing neurons—revealed in all three models the expected up-regulated Coll IV-immunoreactivity (Figures 4C, 5C, 6C), delineating ischemia-affected tissue”
Quote in the paperSubstantial claim - Findingown data
We detected strongly degraded aggrecan in the addressed net components.
“Among the addressed net components, we detected strongly degraded aggrecan”
Quote in the paperSubstantial claim - Findingown data
Overlay demonstrated nearly complementary staining patterns for Coll IV on one hand and WFA and parvalbumin on the other hand.
“Strikingly, the overlay demonstrated nearly complementary staining patterns for Coll IV on the one hand and WFA and parvalbumin on the other hand.”
Quote in the paperNot a substantial claim - Findingown data
Detection of CRTL visualized more PNs than WFA and anti-aggrecan in the presented area.
“whereas the detection of CRTL visualized in the presented area more PNs than WFA and anti-aggrecan (Figures 8C″,C‴).”
Quote in the paperNot a substantial claim - Findingown data
Kv3.1b and parvalbumin were co-localized in all detected neurons.
“In general, Kv3.1b (Figure 9A′) and parvalbumin (Figure 9A″) were co-localized, and in the overlay neurons co-expressing both markers appeared pink (Figure 9A‴).”
Quote in the paperNot a substantial claim - Findingown data
The ischemia-affected area was also largely devoid of neurocan immunolabeling.
“which was also largely devoid of neurocan-immunolabeling (Figures 8A″,A‴).”
Quote in the paperSubstantial claim - Findingown data
In mouse sections, WFA-stained ECM and aggrecan immunolabeling were similarly abolished in the ischemia-affected area.
“Representative mouse sections displayed that the ECM stainable by WFA (Figures 8A–C; green) and aggrecan (Figures 8A′–C′; blue) were similarly abolished in the ischemia-affected area”
Quote in the paperNot a substantial claim - Findingown data
In sheep, activated astrocytes became predominantly visible around the heavily Coll IV-stained region and formed a glia scar-like structure.
“In sheep, activated astrocytes became predominantly visible around the heavily Coll IV-stained region and formed a glia scar-like structure (Figure 6B).”
Quote in the paperNot a substantial claim - Findingown data
In mice and rats, triple fluorescence labeling of Coll IV, WFA and GFAP demonstrated fragmented astrocytes in affected tissue at 1 day after ischemia onset.
“Additional triple fluorescence labeling of Coll IV, WFA and glial fibrillary acidic protein (GFAP) demonstrated in the affected tissue from mice and rats also fragmented astrocytes at 1 day after ischemia onset (Figures 4B, 5B).”
Quote in the paperNot a substantial claim - Findingown data
Semi-quantification of Coll IV confirmed significantly up-regulated immunoreactivity in ischemic areas.
“The added semi-quantification of Coll IV confirmed this observation in terms of a significantly up-regulated immunoreactivity in ischemic areas”
Quote in the paperSubstantial claim - Findingown data
Immunolabeling of versican revealed several damaged PNs in close vicinity to the strongly affected tissue.
“In parallel, immunolabeling of versican revealed several damaged PNs in close vicinity to the strongly affected tissue (Figure 8B″)”
Quote in the paperSubstantial claim - Findingown data
In rat ischemia-affected neocortical tissue, a few remaining PNs were recognized by WFA and anti-aggrecan.
“In parallel, neocortical ischemia-affected rat tissue showed a few remaining PNs recognized by WFA (Figure 7B, green) and anti-aggrecan (Figure 7B′, blue), each exemplified by an arrow.”
Quote in the paperNot a substantial claim - Findingown data
The present study shows erased WFA staining in the neocortices from infarcted mice, rats and sheep.
“In line with these findings, the present study shows erased WFA staining in the neocortices from infarcted mice, rats and sheep”
Quote in the paperSubstantial claim - Findingown data
Apparently healthy tissue displayed strong neuropil staining for neurocan.
“Notably, the apparently healthy tissue displayed a strong neuropil staining for neurocan.”
Quote in the paperNot a substantial claim - Findingown data
The present study provides evidence for diminished neocortical PN markers in association with net-bearing, fast-firing GABAergic neurons such as parvalbumin and Kv3.1b.
“the present study provides evidence for diminished neocortical PN markers in association with net-bearing, fast-firing GABAergic neurons such as parvalbumin and the potassium channel subunit Kv3.1b.”
Quote in the paperSubstantial claim - Findingown data
Qualitative analyses in the present study implicated concomitant degradation of PNs and up-regulation of Coll IV in ischemia-affected neocortices of mice, rats and sheep as the main finding.
“Qualitative analyses in our study implicated the concomitant degradation of PNs and up-regulation of Coll IV in the ischemia-affected neocortices of mice, rats and sheep as the main finding of the present study.”
Quote in the paperSubstantial claim - Findingown data
No cells displaying only one of Kv3.1b or parvalbumin were observed.
“Notably, cells displaying only one of both proteins were not observed.”
Quote in the paperNot a substantial claim - Findingown data
In healthy tissue of all models, numerous WFA-stained PNs were present around parvalbumin-containing neurons.
“while on the contrary, the healthy tissue in all models contained numerous WFA-stained PNs around parvalbumin-containing neurons.”
Quote in the paperSubstantial claim - Findingown data
Contralateral non-affected hemisphere displayed homogeneous patterns for all three applied combinations of markers devoid of any cellular affection.
“In contrast, triple fluorescence labeling in the same areas on the contralateral, non-affected hemisphere displayed homogeneous patterns for all three applied combinations of markers devoid of any cellular affection (Figures 9AIV–CIV).”
Quote in the paperNot a substantial claim - Study design and conductown data
In sheep, cerebral infarcts were observed in the temporal lobe and in the striatum via magnetic resonance tomography.
“In sheep, cerebral infarcts were observed in the temporal lobe and in the striatum via magnetic resonance tomography, while maceration and liquefaction next to brain tissue edema were also macroscopically visible.”
- Also stated in: § Study Design and Induction of Focal Cerebral Ischemia · plain
“In sheep, animals had to present a visible ischemic lesion in the cerebral magnetic resonance tomography (Biograph mMR, Siemens Healthcare, Erlangen, Germany) that was done at the end of the 2-week observational period.”
Quote in the paperSubstantial claim - Also stated in: § Study Design and Induction of Focal Cerebral Ischemia · plain
- Premisecitation
Hobohm et al. (2005) found that 7 days after experimental stroke induced by invasive electrocoagulative occlusion of the middle cerebral artery in rats, PNs were damaged in the primarily affected neocortex and in more distant thalamic nuclei.
“Hobohm et al. (2005) found 7 days after experimental stroke induced by invasive electrocoagulative occlusion of the middle cerebral artery in rats that PNs were damaged in the primarily affected neocortex and in the more distant thalamic nuclei.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hobohm et al., 2005 source
Not checked in the free run.
- Premisecitation
Data on changes in PNs after stroke remain rather limited.
“However, data on the changes in PNs after stroke remain rather limited.”
Quote in the paperSubstantial claim0 of 3 sources checked - Study design and conductcitation
In mice and rats, a Menzies score of at least 2 points was observed during the 24-h observation period, indicating sufficient cerebral ischemia as inclusion criteria.
“In mice and rats, a Menzies score of at least 2 points was observed during the 24-h observation period, indicating sufficient cerebral ischemia as inclusion criteria for entering the study.”
- Also stated in: § Study Design and Induction of Focal Cerebral Ischemia · plain
“Successful induction of stroke in mice and rats was verified by the existence of a relevant neurobehavioral deficit. In detail, during the 24-h observational period, animals had to present at least 2 points on the Menzies score (Menzies et al., 1992), naturally ranging from 0 (no deficit) to 4 (spontaneous contralateral circling).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Menzies et al., 1992 source
Not checked in the free run.
- Also stated in: § Study Design and Induction of Focal Cerebral Ischemia · plain
- Premisecitation
In a first set of experiments, significant alterations of ECM constituents-degraded PNs-were shown in the subcortical nucleus reticularis thalami.
“In a first set of experiments that characterized ischemic consequences to the ECM, we were able to show significant alterations of ECM constituents—i.e., degraded perineuronal nets (PNs)—in the subcortical nucleus reticularis thalami (Härtig et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Härtig et al., 2016 source
Not checked in the free run.
- Premisecitation
The sheep model shares anatomical and pathohistological similarities to the human situation.
“As an advantage, the sheep model shares anatomical and pathohistological similarities to the human situation (Nitzsche et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nitzsche et al., 2015 source
Not checked in the free run.
- Premisecitation
Abolished and decomposed PNs were reported for other animal models of experimentally induced stroke in neocortices of rats.
“Based on WFA staining, abolished and decomposed PNs were also reported for other animal models of experimentally induced stroke in neocortices of rats (Hobohm et al., 2005; Karetko-Sysa et al., 2011; Madinier et al., 2014; Quattromani et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationcitation
Loss of inhibitory neurons immunoreactive for parvalbumin and Kv3.1b might impair GABAergic wiring in the cortical microcircuitry.
“On the contrary, the loss of inhibitory neurons immunoreactive for parvalbumin and Kv3.1b might impair the GABAergic wiring in the cortical microcircuitry (Kubota, 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kubota, 2014 source
Not checked in the free run.
- Premisecitation
After focal cortical ischemia in rats, WFA-binding sites were reduced in the demarcation zone at different time points between 24 h and 60 days after photothrombosis.
“After focal cortical ischemia in rats, WFA- binding sites were found to be reduced in the demarcation zone at different time points between 24 h and 60 days after photothrombosis (Bidmon et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bidmon et al., 1998 source
Not checked in the free run.
- Premisecitation
After thalamic stroke in hypertensive rats, continuous intra-infarct infusion of ChABC enhanced levels of synaptophysin and growth-associated protein 43.
“After thalamic stroke in hypertensive rats, the continuous intra-infarct infusion of ChABC rescued neuronal loss and enhanced levels of synaptophysin and growth-associated protein 43 indicating augmented axonal growth as well as synaptic plasticity to finally ensure overall neuronal function (Chen et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2014 source
Not checked in the free run.
- Premisecitation
Following experimentally induced stroke in aged rats, timely fine-tuned delayed treatment with ChABC did not protect the peri-infarct region.
“Following experimentally induced stroke in aged rats, the timely fine-tuned delayed treatment with ChABC promoted functional recovery and neuroplasticity, but did not protect the peri-infarct region (Soleman et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soleman et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
The immunohistochemical toolbox for studies of sheep brain tissue was considerably extended.
“Thereby, the immunohistochemical toolbox for studies of sheep brain tissue was considerably extended.”
Quote in the paperNot a substantial claim - Premisecitation
Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction modulated activity and mRNA expression of extracellular matrix proteases and their inhibitors.
“Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction reduced PNs, modulated activity and mRNA expression of ECM proteases and their inhibitors, accompanied by enhanced recovery of limb placement ability (Madinier et al., 2014; Quattromani et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction reduced perineuronal nets.
“Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction reduced PNs, modulated activity and mRNA expression of ECM proteases and their inhibitors, accompanied by enhanced recovery of limb placement ability (Madinier et al., 2014; Quattromani et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
After ChABC injection into the rat frontal or occipital cortex, matrix components significantly re-established only after 4 weeks.
“Injections of ChABC into the rat frontal or occipital cortex resulted in the erasure of PNs within 1 day followed by the significant re-establishment of matrix components only after 4 weeks and the rebuilding of PNs only after 5 months (Brückner et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brückner et al., 1998 source
Not checked in the free run.
- Study design and conductown data
The amount of available sheep and rat tissue sections was restricted in this study, which allowed only qualitative investigations in these species.
“However, the amount of available sheep and rat tissue sections was restricted in this study, which allowed only qualitative investigations in these species.”
Quote in the paperSubstantial claim - Study design and conductown data
Immersion fixation of about 1 cm-thick coronal forebrain slices from sheep was possible.
“Notably, it was possible to carry out immersion fixation of about 1 cm-thick coronal forebrain slices from sheep.”
Quote in the paperSubstantial claim - Premisecitation
After thalamic stroke in hypertensive rats, continuous intra-infarct infusion of ChABC rescued neuronal loss.
“After thalamic stroke in hypertensive rats, the continuous intra-infarct infusion of ChABC rescued neuronal loss and enhanced levels of synaptophysin and growth-associated protein 43 indicating augmented axonal growth as well as synaptic plasticity to finally ensure overall neuronal function (Chen et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2014 source
Not checked in the free run.
- Study design and conductown data
At least semi-quantifications were feasible in mice based on n = 5.
“At least semi-quantifications were feasible in mice based on n = 5.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Perineuronal nets critically impact on proper neuronal function.
“This study confirmed that the ECM and in particular PNs are an important component of the NVU, which critically impacts on proper neuronal function.”
Quote in the paperSubstantial claim - Interpretationown data
The extracellular matrix and in particular perineuronal nets are an important component of the neurovascular unit.
“This study confirmed that the ECM and in particular PNs are an important component of the NVU, which critically impacts on proper neuronal function.”
Quote in the paperSubstantial claim - Study design and conductnone given
Several presented staining methods were well applicable in all three animal species analyzed.
“Notably, several presented staining methods were well applicable in all three animal species analyzed.”
Quote in the paperSubstantial claim - Premisecitation
After thalamic stroke in hypertensive rats, continuous intra-infarct infusion of ChABC ensured overall neuronal function.
“After thalamic stroke in hypertensive rats, the continuous intra-infarct infusion of ChABC rescued neuronal loss and enhanced levels of synaptophysin and growth-associated protein 43 indicating augmented axonal growth as well as synaptic plasticity to finally ensure overall neuronal function (Chen et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2014 source
Not checked in the free run.
- Premisecitation
Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction was accompanied by enhanced recovery of limb placement ability.
“Following cortical photothrombotic stroke in rats, enriched housing after ischemia induction reduced PNs, modulated activity and mRNA expression of ECM proteases and their inhibitors, accompanied by enhanced recovery of limb placement ability (Madinier et al., 2014; Quattromani et al., 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Study design and conductreasoning
Despite the use of a broad spectrum of antibodies, comparable immunolabeling of diverse cellular and extracellular matrix structures across the three animal species was in some parts hampered because of differences in post-ischemic tissue processing including fixation.
“First, despite the use of a broad spectrum of antibodies, a comparable immunolabeling of diverse cellular and ECM structures across the three animal species was in some parts hampered because of some differences in the post-ischemic tissue processing including fixation.”
Quote in the paperNot a substantial claim - Premisecitation
After ChABC injection into the rat frontal or occipital cortex, perineuronal nets rebuilt only after 5 months.
“Injections of ChABC into the rat frontal or occipital cortex resulted in the erasure of PNs within 1 day followed by the significant re-establishment of matrix components only after 4 weeks and the rebuilding of PNs only after 5 months (Brückner et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brückner et al., 1998 source
Not checked in the free run.
- May combine two claims. 29
- Classified as probably not a substantial claim. 37
May combine two claims.
Findingown dataIn all three species investigated, nearly complementary distribution patterns for WFA and massively enhanced Coll IV immunoreactivity were found.
“Thereby, nearly complementary distribution patterns for WFA and massively enhanced Coll IV-immunoreactivity was found in all three species investigated (Figures 4A, 5A, 6A,A′).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA considerable loss of WFA-stainable ECM and decomposed PNs were noted in whole forebrain sections including affected somatosensory cortex and dorsal striatum, as well as visual and auditory cortical areas, hippocampal formation and pontine gray matter.
“A considerable loss of WFA-stainable ECM and decomposed PNs were noted as exemplified by images from whole forebrain sections including affected somatosensory cortex and dorsal striatum (Figure 1A), as well as visual and auditory cortical areas, hippocampal formation and pontine gray matter (Figure 1B).”
Quote in the paperSubstantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
May combine two claims.
Findingown dataColl IV immunofluorescence is significantly up-regulated in the ischemia-affected hemisphere compared with the contralateral hemisphere, corresponding with relatively reduced WFA signal from medial to lateral neocortex.
“shows a significant up-regulation of the Coll IV-fluorescence signal that corresponds with a relatively reduced lectin-histochemical signal for WFA alongside from the medial to the lateral part of the neocortex.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMorphological changes of PN structures became visible at high magnification by confocal laser-scanning microscopy.
“Morphological changes of PN structures became visible at high magnification by confocal laser-scanning microscopy.”
Quote in the paperNot a substantial claim- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
May combine two claims.
Findingown dataIn the contralateral (non-ischemic) hemisphere, WFA-binding significantly increases from the second to the third ROI and from the fourth to the fifth ROI (each p = 0.043; Wilcoxon test, n = 5).
“Thereby, a significant increase occurred from the second (19.2 × 1011 ± 11.0 × 1011) to the third (27.3 × 1011 ± 15.8 × 1011) as well as between the fourth (34.8 × 1011 ± 18.2 × 1011) to the fifth (45.7 × 1011 ± 20.6 × 1011) ROI (each p = 0.043; Wilcoxon test, n = 5).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOn the ischemia-affected hemisphere, WFA-binding significantly decreases from the first to the third ROI and then increases toward the fifth ROI (each p = 0.043; Wilcoxon test, n = 5).
“On the ischemia-affected hemisphere (white bars in Figure 3C), WFA-binding exhibited a shaped course in the bordering zone of ischemia by decreasing significantly from the first (17.7 × 1011 ± 11.6 × 1011) to the third (9.28 × 1011 ± 10.7 × 1011), followed by an increase towards the fifth (17.5 × 1011 ± 11.4 × 1011) ROIs (each p = 0.043; Wilcoxon test, n = 5).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn sheep 14 days after infarction, strongly Iba-labeled microglia/macrophages are observed in the Coll IV-stained region, contrasted by ameboid and ramified microglial cells near PNs.
“However, in the representative image from the ischemic border zone of the sheep 14 days after infarction (Figure 6A), strongly Iba-labeled microglia/macrophages can be observed in the Coll IV-stained region, contrasted by ameboid and ramified microglial cells in vicinity to PNs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe ischemia-affected region contained structures with diminished NeuN immunoreactivity without an immunosignal for Kv3.1b, and only parvalbumin-stained coarse neuropil as well as a few remnants of shrunken neurons.
“On the contrary, the ischemia-affected region contained structures with diminished NeuN-immunoreactivity (Figures 9B″,C′) without an immunosignal for Kv3.1b (Figure 9B‴), and only parvalbumin-stained coarse neuropil as well as a few remnants of shrunken neurons (Figure 9C″).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the same area, WFA-stained nets appeared decomposed or were even abolished.
“whereas in the same area WFA-stained nets appeared decomposed (Figures 4C′, 6C′) or were even abolished (Figure 5C′).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFluorescence labeling verified the occurrence of PNs double-positive for WFA and aggrecan or only for one of both markers.
“The fluorescence labeling also verified the occurrence of PNs double-positive for WFA and aggrecan or only for one of both markers.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn rat, parvalbumin immunolabeling was severely affected, only a few apparently intact PNs surrounded cells with detectable calcium-binding protein remained, and the neuropil appeared coarse.
“Concomitantly, parvalbumin-immunolabeling (Figure 7B″) was severely affected, while only a few apparently intact PNs surrounded cells with detectable calcium-binding protein remained and the neuropil appeared again coarse.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn mouse neocortex, healthy tissue had evenly distributed PNs, while ischemia-affected areas were either devoid of WFA-labeled structures or exhibited only some remnants of nets.
“In contrast to the rather evenly distributed PNs in the healthy tissue, the ischemia-affected areas were either devoid of WFA-labeled structures (Figure 9A) or exhibited only some remnants of nets (Figures 9B,C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn mice, parvalbumin in affected tissue was diminished in cells and in the neuropil with a coarser appearance than in healthy tissue.
“After merging of staining patterns for PNs and parvalbumin, the calcium-binding protein was also observed in affected tissue, i.e., diminished in cells and in the neuropil with a coarser appearance than in healthy tissue (Figure 7A″).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMerge of staining patterns visualized PNs double-labeled by WFA and anti-aggrecan.
“As expected, the merge of staining patterns also visualized PNs double-labeled by WFA and anti-aggrecan (Figure 7B″).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOverlay elucidated triple-stained nets, numerous WFA/aggrecan co-labeled nets, and nets mono-labeled by WFA.
“The overlay (Figures 8A‴,B‴,C‴) elucidated triple-stained nets (arrows), numerous WFA/aggrecan co-labeled nets (arrowheads) and nets mono-labeled by WFA (two-headed arrow).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParvalbumin immunolabeling detected shrunken cells and, especially in the rat, enhanced labeling of neuropil in the same area.
“Parvalbumin-immunolabeling (Figures 4C″, 5C″, 6C″) detected shrunken cells and especially in the rat (Figure 5C″) combined with enhanced labeling of neuropil in the same area.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn mice, the ischemia-affected neocortical area had lowered lectin-staining of the neuropil and was devoid of PNs detected by WFA and aggrecan.
“Thereby, mice displayed a neocortical ischemia-affected area with lowered lectin-staining of the neuropil and devoid of PNs detected by WFA (Figure 7A) and aggrecan (Figure 7A′).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the ischemia-affected zone, merged staining patterns revealed only a few PNs around parvalbumin-containing neurons or even the absence of such net-enwrapped neurons.
“In the ischemia-affected zone, merged staining patterns revealed only a few PNs around parvalbumin-containing neurons (Figure 4C‴) or even the absence of such net-enwrapped neurons (Figures 5C‴, 6C‴)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverlay visualized co-localized WFA-binding sites and aggrecan immunoreactivity as well as parvalbumin-containing cells devoid of PNs.
“The overlay further visualized co-localized WFA-binding sites and aggrecan-immunoreactivity as well as parvalbumin-containing cells devoid of PNs.”
Quote in the paperNot a substantial claimMay combine two claims.
Premiseown dataPrevious histochemical analyses after experimental stroke in mice revealed significant alterations of vascular components, microtubule-associated protein tau, and vesicular neurotransmitter transporters.
“Based on the NVU concept, our own histochemical analyses after experimental stroke in mice revealed significant alterations of vascular components (Hawkes et al., 2013; Krueger et al., 2015), microtubule-associated protein tau (Michalski et al., 2016) and vesicular neurotransmitter transporters (Michalski et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Hawkes et al., 2013
Not checked in the free run.
- cites Krueger et al., 2015
Not checked in the free run.
- cites Michalski et al., 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationKaretko-Sysa et al. (2011) reported disturbance of PNs after focal photothrombotic stroke.
“Additionally, Karetko-Sysa et al. (2011) reported the disturbance of PNs after focal photothrombotic stroke.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karetko-Sysa et al., 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMice and rats were randomly included in the study.
“The study was carried out with n = 5 C57BL/6 mice of about 25 g body weight and n = 3 Wistar rats of about 300 g body weight (both breed by Charles River, Sulzfeld, Germany), which were randomly included, and with three male adult sheep from the nucleus breed of the educational manor (Faculty for Veterinary Medicine, University of Leipzig).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe NVU concept also involves the adjacent extracellular matrix (ECM), which is known to critically impact a variety of cellular functions.
“Of note, this concept also involves the adjacent extracellular matrix (ECM) which is known to critically impact on a variety of cellular functions (del Zoppo, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites del Zoppo, 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIschemia-induced damage of PNs in rat neocortices was analyzed by Bidmon et al. (1998) and by Wieloch's research group using a similar animal model.
“Using a similar animal model, ischemia-induced damage of PNs in rat neocortices was analyzed by Bidmon et al. (1998) and by Wieloch’s research group (Madinier et al., 2014; Quattromani et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
Study design and conductnone givenThresholds were adjusted individually for each staining until background intensity could be nearly excluded without affecting visualization of targeted structures.
“Thresholds had been adjusted individually for each staining until the background intensity could be nearly excluded without affecting the visualization of targeted structures to prevent adulterations of the applied measurements.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPerineuronal nets (PNs) are polyanionic, chondroitin sulfate proteoglycan (CSPG)-rich coatings of certain neurons.
“As part of the extracellular matrix (ECM), perineuronal nets (PNs) are polyanionic, chondroitin sulfate proteoglycan (CSPG)-rich coatings of certain neurons, known to be affected in various neural diseases.”
- Also stated in: § Introduction · plain
“PNs represent polyanionic lattice-like coatings of neurons (Brückner et al., 1993; Celio and Blümcke, 1994; Oohashi et al., 2015; Sorg et al., 2016).”
Quote in the paperNot a substantial claim0 of 3 sources checked- Also stated in: § Introduction · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPNs frequently surround neurons containing parvalbumin, which are fast-firing GABAergic neurons co-expressing the voltage-gated potassium channel Kv3.1b.
“PNs frequently surround neurons containing parvalbumin (Kosaka and Heizmann, 1989; Härtig et al., 1992), known as a marker for fast-firing GABAergic neurons co-expressing the voltage-gated potassium channel Kv3.1b (Härtig et al., 1999).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPNs are composed of chondroitin sulfate proteoglycans (CSPGs) and their glycosaminoglycans, hyaluronic acid and tenascins, produced by various neural cell types.
“They are composed of chondroitin sulfate proteoglycans (CSPGs) and their glycosaminoglycans, hyaluronic acid and tenascins, produced by various neural cell types (Brückner et al., 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brückner et al., 1993 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAnimal experiments were performed according to the European Union Directive 2010/63/EU and the protocol was approved by the local authority.
“Animal experiments were performed according to the European Union Directive 2010/63/EU and the protocol was approved by the local authority (Regierungspräsidium Leipzig; reference numbers: TVV 51/14 for mice, TVV 34/11 for rats and TVV 56/15 for sheep).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataConsistent observations based on three different stroke models confirmed that PNs are highly sensitive constituents of the NVU along with impaired associated GABAergic neurons.
“In summary, theconsistent observations based on three different stroke models confirmed that PNs are highly sensitive constituents of the NVU along with impaired associated GABAergic neurons.”
Quote in the paperSubstantial claim- Rests on an assumption: The three stroke models and their different survival times are comparable enough to support a common conclusion about PN sensitivity.
- Rests on an assumption: Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenControl experiments omitting primary antibodies or biotinylated WFA resulted in the expected absence of cellular labeling.
“In control experiments, the omission of primary antibodies or biotinylated WFA resulted in the expected absence of cellular labeling.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThe type of ischemia induction and the selection of a single stroke model were discussed as reasons for the translational roadblock.
“Notably, as another reason for the translational roadblock the type of ischemia induction, i.e., the widely used artificial stroke models (Young et al., 2007; Sommer, 2017) and the selection of a single stroke model (Fisher et al., 2009) were discussed.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Young et al., 2007
Not checked in the free run.
- cites Sommer, 2017
Not checked in the free run.
- cites Fisher et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBrightness and contrast of micrographs were slightly adjusted without deletion or creation of signals.
“If necessary, brightness and contrast of micrographs were slightly adjusted without deletion or creation of signals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe neurovascular unit (NVU) concept comprises ischemia-affected neurons as well as vessels, micro-, astro- and oligodendroglia.
“In this view, the concept of the “neurovascular unit” (NVU) as outlined by del Zoppo (2009, 2010) comprised ischemia-affected neurons as well as vessels, micro-, astro- and oligodendroglia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites del Zoppo (2009, 2010)
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningFor all fluorescence measurements, the threshold was adjusted to the contralateral hemisphere and kept constant at gray values of 1000 for WFA and 1250 for Coll IV to correct for background intensities.
“For all measurements, the threshold was adjusted to the contralateral hemisphere and kept constant at gray values of 1000 for WFA and 1250 for Coll IV to correct for any background intensities relating to non-labeled areas, such as the lumen of cross-sectioned vessels.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChondroitinase ABC (ChABC) is an established tool for remodeling the extracellular matrix and especially perineuronal nets in vivo and under pathological conditions.
“An established tool for the remodeling the ECM and especially PNs in vivo and even under pathological conditions are bacterial glycosaminoglycan-degrading enzymes such as chondroitinase ABC (ChABC) as reviewed by Burnside and Bradbury (2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Burnside and Bradbury (2014)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSuch enzymes were observed in net-ensheathed parvalbumin-immunoreactive neurons.
“Interestingly, such enzymes were observed in net-ensheathed parvalbumin-immunoreactive neurons (Rossier et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rossier et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe same enzymes later contribute to beneficial mechanisms of neurovascular remodeling.
“However, the same enzymes later contribute to beneficial mechanisms of neurovascular remodeling (Lo, 2008; Rosell and Lo, 2008; del Zoppo, 2010)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Lo, 2008
Not checked in the free run.
- cites Rosell and Lo, 2008 source
Not checked in the free run.
- cites del Zoppo, 2010
Not checked in the free run.
May combine two claims.
PremisecitationThe filament model in mice allows non-invasive induction of focal cerebral ischemia and leads to reproducible infarction in the middle cerebral artery territory, enabling robust quantifications on cellular reactions.
“Thereby, the filament model in mice (Longa et al., 1989) allowed non-invasive induction of focal cerebral ischemia and led to reproducible infarction in the territory of the middle cerebral artery (Longa et al., 1989; Durukan and Tatlisumak, 2007; Engel et al., 2011), enabling robust quantifications on cellular reactions.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Longa et al., 1989 source
Not checked in the free run.
- cites Durukan and Tatlisumak, 2007
Not checked in the free run.
- cites Engel et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationThe applied thromboembolic rat model is currently considered the most patient-near animal model because the ischemic event is strictly caused by an embolus, matching the human situation where cardio-embolism and arterial embolism are the most frequent causes of stroke.
“The applied thromboembolic rat model is currently considered as the most patient-near animal model, since the ischemic event is strictly caused by an embolus in excellent accordance to the human situation where cardio-embolism due to atrial fibrillation and arterial embolism—based on arteriosclerosis or carotid stenosis—accounts for the most frequent causes of stroke (Durukan and Tatlisumak, 2007;”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Durukan and Tatlisumak, 2007
Not checked in the free run.
- cites Young et al., 2007
Not checked in the free run.
- cites Sommer, 2017
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationCurrent recommendations state that implementation of gyrencephalic, large animal models in preclinical stroke research is desirable.
“According to current recommendations for improving experimental stroke research (Stroke Therapy Academic Industry Roundtable (STAIR), 1999; Fisher et al., 2009), an implementation of gyrencephalic, large animal models in preclinical stroke research is desirable.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Stroke Therapy Academic Industry Roundtable (STAIR), 1999
Not checked in the free run.
- cites Fisher et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationImmediately after stroke, matrix metalloproteinases become dysregulated and are associated with acute neurovascular disruption.
“Immediately after stroke, matrix metalloproteinases are known to become dysregulated (Heo et al., 1999) and associated with acute neurovascular disruption.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Heo et al., 1999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInjections of ChABC into the rat frontal or occipital cortex resulted in the erasure of perineuronal nets within 1 day.
“Injections of ChABC into the rat frontal or occipital cortex resulted in the erasure of PNs within 1 day followed by the significant re-establishment of matrix components only after 4 weeks and the rebuilding of PNs only after 5 months (Brückner et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brückner et al., 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe robustly observed up-regulation of Coll IV across the three animal models might be seen in the context of matrix metalloproteinases.
“the robustly observed up-regulation of Coll IV across the three animal models might be seen in the context of these mediators.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThis finding is in line with the recently reported heterogeneity of PNs in the mouse hippocampus.
“This finding is in line with the recently reported heterogeneity of PNs in the mouse hippocampus (Yamada and Jinno, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yamada and Jinno, 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAggrecanases (ADAMTS-1, 4, 8, 15) and neprilysin are further candidate enzymes for stroke-induced degradation of net components.
“Further candidates for the stroke-induced degradation of net components are aggrecanases, e.g., disintegrin and metalloproteinase with thrompospondin motifs (ADAMTS-1, 4, 8 and 15) and neprilysin (Cross et al., 2006; Lemarchant et al., 2013; Levy et al., 2015; Rossier et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Cross et al., 2006
Not checked in the free run.
- cites Lemarchant et al., 2013 source
Not checked in the free run.
- cites Levy et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationRemoval of PN coatings might allow formerly net-enwrapped parvalbumin-containing neurons to re-open a more plastic state.
“The removal of their coatings might allow formerly net-enwrapped parvalbumin-containing neurons to re-open a more plastic state (Hensch, 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hensch, 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMatrix metalloproteinases influence vascular integrity and the ischemic stimulus promotes production of matrix metalloproteinases.
“as matrix metalloproteinases have been considered to influence the vascular integrity and the ischemic stimulus is known to promote the production of matrix metalloproteinases (del Zoppo, 2009, 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites del Zoppo, 2009, 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAggrecan is known as the predominant CSPG in PNs, occurring in several isoforms with differential distribution as shown for the human cerebral cortex.
“aggrecan known as predominant CSPG in PNs occurring in several isoforms (Matthews et al., 2002; Morawski et al., 2012a) with differential distribution as shown for the human cerebral cortex (Virgintino et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Matthews et al., 2002 source
Not checked in the free run.
- cites Morawski et al., 2012a
Not checked in the free run.
- cites Virgintino et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnhanced levels of synaptophysin and growth-associated protein 43 indicate augmented axonal growth and synaptic plasticity.
“After thalamic stroke in hypertensive rats, the continuous intra-infarct infusion of ChABC rescued neuronal loss and enhanced levels of synaptophysin and growth-associated protein 43 indicating augmented axonal growth as well as synaptic plasticity to finally ensure overall neuronal function (Chen et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningSheep brains were not perfusion-fixed due to experimental constraints of the underlying sheep studies.
“In detail, sheep brains were not perfusion-fixed, which was due to the experimental constraints of the underlying sheep studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChABC injections into perirhinal cortices from transgenic mice with tau pathology restored object recognition memory.
“Remarkably, ChABC injections into perirhinal cortices from transgenic mice with tau pathology restored even the object recognition memory of these animals (Yang et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yang et al., 2015 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPost-stroke reactions have been described in a multi-phasic fashion.
“Given the fact that post-stroke reactions were described in a multi-phasic fashion (Dirnagl et al., 1999), additional work is necessary to explore the longitudinal course of addressed markers.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dirnagl et al., 1999
Not checked in the free run.
May combine two claims.
PremisecitationFollowing experimentally induced stroke in aged rats, timely fine-tuned delayed treatment with ChABC promoted functional recovery and neuroplasticity.
“Following experimentally induced stroke in aged rats, the timely fine-tuned delayed treatment with ChABC promoted functional recovery and neuroplasticity, but did not protect the peri-infarct region (Soleman et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soleman et al., 2012
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningFrozen tissue sections from these blocs allowed for the detection of perineuronal nets and multiple vascular, glial and neuronal markers.
“Consequently, frozen tissue sections from these blocs allowed for the detection of PNs and multiple vascular, glial and neuronal markers.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenExperiments were limited to a single time point: 24 h after ischemia induction in rodents, and 14 days after ischemia induction in sheep.
“It is also noteworthy that experiments were limited to a single time point (i.e., 24 h after ischemia induction in rodents, and 14 days after ischemia induction in sheep).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChABC-induced removal of perineuronal nets in the medial prefrontal cortex impaired acquisition and reconsolidation of conditioned place preference memory after its impairment by cocaine.
“Moreover, the ChABC-induced removal of PNs in the medial prefrontal cortex impaired acquisition and reconsolidation of conditioned place preference memory after its impairment by cocaine (Slaker et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Slaker et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChABC-induced removal of negatively charged extracellular matrix components such as glycosaminoglycans resulted in enhanced calcium diffusion within brain tissue.
“Notably, the ChABC-induced removal of negatively charged ECM components such as glycosaminoglycans resulted in enhanced calcium diffusion within brain tissue which influences synaptic transmission, neuronal excitability and other physiological processes (Hrabětová et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hrabětová et al., 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnhanced calcium diffusion within brain tissue influences synaptic transmission, neuronal excitability and other physiological processes.
“Notably, the ChABC-induced removal of negatively charged ECM components such as glycosaminoglycans resulted in enhanced calcium diffusion within brain tissue which influences synaptic transmission, neuronal excitability and other physiological processes (Hrabětová et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hrabětová et al., 2009 source
Not checked in the free run.
The paper relies on this without support.
The contralateral hemisphere is non-affected and valid as an internal control for the ischemic hemisphere.
“For controls, the pattern of the eight ROIs in the ischemic hemisphere was mirrored to the contralateral, non-affected hemisphere, resulting in 16 ROIs in each of the three brain sections per animal.”
“To consider the natural patterns of PN components, the mirrored ROIs on the contralateral hemisphere served as controls (Figure 3A).”
The paper relies on this without support.
The three stroke models and their different survival times are comparable enough to support a common conclusion about PN sensitivity.
“By employing three models of experimental focal cerebral ischemia, this study was focused on histopathological alterations of PNs and concomitant vascular, glial and neuronal changes according to the NVU concept.”
“In summary, theconsistent observations based on three different stroke models confirmed that PNs are highly sensitive constituents of the NVU along with impaired associated GABAergic neurons.”
The paper relies on this without support.
Loss of WFA-staining and other marker changes reflect decomposition of PNs rather than reversible downregulation or masking of epitopes.
“A considerable loss of WFA-stainable ECM and decomposed PNs were noted as exemplified by images from whole forebrain sections including affected somatosensory cortex and dorsal striatum (Figure 1A), as well as visual and auditory cortical areas, hippocampal formation and pontine gray matter (Figure 1B).”
“Morphological changes of PN structures became visible at high magnification by confocal laser-scanning microscopy.”
The authors state this as an assumption.
The medial-to-lateral increase in WFA-staining in the non-ischemic hemisphere represents the natural course in this neocortical region.
“which is assumed to represent the natural course in this neocortical region.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Similar degradation of WFA-expressing PNNs in the neocortex has also been observed following thromboembolic middle cerebral artery occlusion in rats, permanent middle artery occlusion in mice, and focal cerebral ischemia in sheep.
“Similar degradation of WFA-expressing PNNs in the neocortex has also been observed following thromboembolic middle cerebral artery occlusion in rats, permanent middle artery occlusion in mice, and focal cerebral ischemia in sheep (Härtig et al., 2017).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Härtig et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 8 is assigned to both mouse and rat tissue
MinorThe results describe the sections shown in Figure 8 as mouse sections, but the Figure 8 caption identifies the tissue as rat neocortex.
“Representative mouse sections displayed that the ECM stainable by WFA (Figures 8A–C; green)”
“Figure: Figure 8 Ischemia-affected net constituents neurocan, versican and cartilage link protein (CRTL) vs. decomposed WFA-binding and aggrecan-containing PNs in rat neocortex.”
Figure 5C′′′ is described as showing both absent and remaining net-enwrapped neurons
MinorThe results cite Figure 5C′′′ as showing an absence of net-enwrapped parvalbumin-containing neurons in the affected zone, while its caption says a few PNs remain around those neurons.
“or even the absence of such net-enwrapped neurons (Figures 5C‴, 6C‴)”
“where the overlay (C‴) elucidates only a few PNs around parvalbumin-containing neurons.”
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463 · see citing works
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · see citing works
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,674 · see citing works
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · see citing works
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930 · see citing works
1,026 Experimental treatments in acute stroke
O’Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, H. B., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,453 · see citing works
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352 · see citing works
Roundtable, S. T. A. I. (1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,258 · see citing works
Perineuronal Nets Protect Fear Memories from Erasure
Gogolla, N., Caroni, P., Lüthi, A., & Herry, C. (2009) · Science · doi:10.1126/science.1174146 · Cited by 760 · see citing works
Durukan, A., & Tatlisumak, T. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.015 · Cited by 733 · see citing works
A new penumbra: transitioning from injury into repair after stroke
Lo, E. H. (2008) · Nature Medicine · doi:10.1038/nm1735 · Cited by 611 · see citing works
Ischemic stroke: experimental models and reality
Sommer, C. J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1667-0 · Cited by 599 · see citing works
The dual role of the extracellular matrix in synaptic plasticity and homeostasis
Dityatev, A., Schachner, M., & Sonderegger, P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2898 · Cited by 559 · see citing works
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
Heo, J. H., Lucero, J. D., Abumiya, T., Koziol, J. A., Copeland, B. R., & del Zoppo, G. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00005 · Cited by 547 · see citing works
Perineuronal nets protect fast-spiking interneurons against oxidative stress
Cabungcal, J.-H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300454110 · Cited by 512 · see citing works
Perineuronal nets: past and present
Celio, M. R., Spreafico, R., De Biasi, S., & Vitellaro-Zuccarello, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01298-3 · Cited by 497 · see citing works
Animals lacking link protein have attenuated perineuronal nets and persistent plasticity
Carulli, D., Pizzorusso, T., Kwok, J. C. F., Putignano, E., Poli, A., Forostyak, S., Andrews, M. R., Deepa, S. S., Glant, T. T., & Fawcett, J. W. (2010) · Brain · doi:10.1093/brain/awq145 · Cited by 495 · see citing works
Casting a Wide Net: Role of Perineuronal Nets in Neural Plasticity
Sorg, B. A., Berretta, S., Blacktop, J. M., Fawcett, J. W., Kitagawa, H., Kwok, J. C. F., & Miquel, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2351-16.2016 · Cited by 454 · cited 3× · see citing works
“PNs represent polyanionic lattice-like coatings of neurons (Brückner et al., 1993; Celio and Blümcke, 1994; Oohashi et al., 2015; Sorg et al., 2016).”
BackgroundWisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons
Härtig, W., Brauer, K., & Brückner, G. (1992) · NeuroReport · doi:10.1097/00001756-199210000-00012 · Cited by 440 · see citing works
Self-citationExtracellular matrix and perineuronal nets in CNS repair
Kwok, J. C. F., Dick, G., Wang, D., & Fawcett, J. W. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20974 · Cited by 395 · see citing works
Perineuronal nets — a specialized form of extracellular matrix in the adult nervous system
Celio, M. R., & Blümcke, I. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90006-x · Cited by 386 · see citing works
Brückner, G., Brauer, K., Härtig, W., Wolff, J. R., Rickmann, M. J., Derouiche, A., Delpech, B., Girard, N., Oertel, W. H., & Reichenbach, A. (1993) · Glia · doi:10.1002/glia.440080306 · Cited by 358 · see citing works
Self-citationAggrecan Glycoforms Contribute to the Molecular Heterogeneity of Perineuronal Nets
Matthews, R. T., Kelly, G. M., Zerillo, C. A., Gray, G., Tiemeyer, M., & Hockfield, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07536.2002 · Cited by 341 · see citing works
Härtig, W., Derouiche, A., Welt, K., Brauer, K., Grosche, J., Mäder, M., Reichenbach, A., & Brückner, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01784-9 · Cited by 339 · see citing works
Self-citationA rat model of focal embolic cerebral ischemia
Zhang, R. L., Chopp, M., Zhang, Z. G., Jiang, Q., & Ewing, J. R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00580-5 · Cited by 332 · see citing works
Pantazopoulos, H., Woo, T.-U. W., Lim, M. P., Lange, N., & Berretta, S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.196 · Cited by 296 · see citing works
Mauney, S. A., Athanas, K. M., Pantazopoulos, H., Shaskan, N., Passeri, E., Berretta, S., & Woo, T.-U. W. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.007 · Cited by 291 · see citing works
Modulation of Neural Plasticity as a Basis for Stroke Rehabilitation
Pekna, M., Pekny, M., & Nilsson, M. (2012) · Stroke · doi:10.1161/strokeaha.112.654228 · Cited by 258 · see citing works
Improving Outcome after Stroke: Overcoming the Translational Roadblock
Endres, M., Engelhardt, B., Koıstınaho, J., Lindvall, O., Meairs, S. P., Mohr, J. P., Planas, A. M., Rothwell, N. J., Schwaninger, M., Schwab, M. E., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000118039 · Cited by 256 · see citing works
Perineuronal nets potentially protect against oxidative stress
Morawski, M., Brückner, M. K., Riederer, P., Brückner, G., & Arendt, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.017 · Cited by 246 · see citing works
Very long-term memories may be stored in the pattern of holes in the perineuronal net
Tsien, R. Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310158110 · Cited by 244 · see citing works
Inflammation and the neurovascular unit in the setting of focal cerebral ischemia
del Zoppo, G. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.028 · Cited by 243 · see citing works
Multiphasic roles for matrix metalloproteinases after stroke
ROSELL, A., & LO, E. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.001 · Cited by 215 · see citing works
Krueger, M., Bechmann, I., Immig, K., Reichenbach, A., Härtig, W., & Michalski, D. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.199 · Cited by 211 · see citing works
Self-citationSlaker, M., Churchill, L., Todd, R. P., Blacktop, J. M., Zuloaga, D. G., Raber, J., Darling, R. A., Brown, T. E., & Sorg, B. A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3592-14.2015 · Cited by 208 · see citing works
Extracellular matrix components associated with remodeling processes in brain
Rauch, U. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-004-4043-x · Cited by 205 · see citing works
Brückner, G., Hausen, D., Härtig, W., Drlicek, M., Arendt, T., & Brauer, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00071-8 · Cited by 196 · see citing works
Self-citationLander, C., Kind, P., Maleski, M., & Hockfield, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-06-01928.1997 · Cited by 195 · see citing works
Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model
Engel, O., Kolodziej, S., Dirnagl, U., et al. (2011) · Journal of Visualized Experiments · doi:10.3791/2423 · Cited by 192 · see citing works
Untangling GABAergic wiring in the cortical microcircuit
Kubota, Y. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.10.003 · Cited by 172 · see citing works
Brückner, G., Bringmann, A., Härtig, W., Köppe, G., Delpech, B., & Brauer, K. (1998) · Experimental Brain Research · doi:10.1007/s002210050463 · Cited by 162 · see citing works
Self-citationMorawski, M., Brückner, G., Jäger, C., Seeger, G., Matthews, R. T., & Arendt, T. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00557.x · Cited by 157 · see citing works
Fawcett, J. W. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.02.001 · Cited by 156 · see citing works
Pantazopoulos, H., Markota, M., Jaquet, F., Ghosh, D., Wallin, A., Santos, A., Caterson, B., & Berretta, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.128 · Cited by 153 · see citing works
Kosaka, T., & Heizmann, C. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)90048-6 · Cited by 153 · see citing works
Burnside, E. R., & Bradbury, E. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12114 · Cited by 153 · see citing works
Berretta, S., Pantazopoulos, H., Markota, M., Brown, C., & Batzianouli, E. T. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.040 · Cited by 152 · see citing works
Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology
Yang, S., Cacquevel, M., Saksida, L. M., Bussey, T. J., Schneider, B. L., Aebischer, P., Melani, R., Pizzorusso, T., Fawcett, J. W., & Spillantini, M. G. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.11.013 · Cited by 138 · see citing works
Aggrecan: Beyond cartilage and into the brain
Morawski, M., Brückner, G., Arendt, T., & Matthews, R. T. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.010 · Cited by 136 · see citing works
Oohashi, T., Edamatsu, M., Bekku, Y., & Carulli, D. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.09.010 · Cited by 131 · see citing works
Soleman, S., Yip, P. K., Duricki, D. A., & Moon, L. D. F. (2012) · Brain · doi:10.1093/brain/aws027 · Cited by 123 · see citing works
Chondroitin sulphate proteoglycans: Key modulators of spinal cord and brain plasticity
Bartus, K., James, N. D., Bosch, K. D., & Bradbury, E. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.008 · Cited by 117 · see citing works
Morawski, M., Reinert, T., Meyer-Klaucke, W., Wagner, F. E., Tröger, W., Reinert, A., Jäger, C., Brückner, G., & Arendt, T. (2015) · Scientific Reports · doi:10.1038/srep16471 · Cited by 116 · see citing works
Neuroprotection and stroke: time for a compromise
Young, A. R., Ali, C., Duretete, A., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04866.x · Cited by 114 · see citing works
Hrabětová, S., Masri, D., Tao, L., Xiao, F., & Nicholson, C. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.170092 · Cited by 113 · see citing works
The neurovascular unit, matrix proteases, and innate inflammation
del Zoppo, G. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05760.x · Cited by 109 · see citing works
Protective Properties of Neural Extracellular Matrix
Suttkus, A., Morawski, M., & Arendt, T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8990-4 · Cited by 108 · see citing works
Hobohm, C., Günther, A., Grosche, J., Roßner, S., Schneider, D., & Brückner, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20459 · Cited by 103 · see citing works
Rossier, J., Bernard, A., Cabungcal, J.-H., Perrenoud, Q., Savoye, A., Gallopin, T., Hawrylycz, M., Cuénod, M., Do, K., Urban, A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.162 · Cited by 101 · see citing works
Meairs, S. P., Wahlgren, N. G., Dirnagl, U., Lindvall, O., Rothwell, P. M., Baron, J., Hossmann, K. A., Engelhardt, B., Ferro, J. M., McCulloch, J., et al. (2006) · Cerebrovascular Diseases · doi:10.1159/000093098 · Cited by 101 · see citing works
Perineuronal net degradation in epilepsy
Rankin‐Gee, E. K., McRae, P. A., Baranov, E., Rogers, S., Wandrey, L., & Porter, B. E. (2015) · Epilepsia · doi:10.1111/epi.13026 · Cited by 100 · see citing works
Boltze, J., Förschler, A., Nitzsche, B., Waldmin, D., Hoffmann, A., Boltze, C., Dreyer, A. Y., Goldammer, A., Reischauer, A., Härtig, W., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.89 · Cited by 97 · see citing works
Self-citationADAMTS proteoglycanases in the physiological and pathological central nervous system.
Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-133 · Cited by 96 · cited 2× · see citing works
“, disintegrin and metalloproteinase with thrompospondin motifs (ADAMTS-1, 4, 8 and 15) and neprilysin (Cross et al., 2006; Lemarchant et al., 2013; Levy et al., 2015; Rossier et al., 2015).”
BackgroundRemodeling of extracellular matrix and epileptogenesis
Dityatev, A. E. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02612.x · Cited by 86 · see citing works
Persistent decrease in multiple components of the perineuronal net following status epilepticus
McRae, P. A., Baranov, E., Rogers, S. L., & Porter, B. E. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08268.x · Cited by 85 · see citing works
Madinier, A., Quattromani, M. J., Sjölund, C., Ruscher, K., & Wieloch, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093121 · Cited by 82 · see citing works
Repeated Binge Drinking Increases Perineuronal Nets in the Insular Cortex
Chen, H., He, D., & Lasek, A. W. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12847 · Cited by 77 · see citing works
Bidmon, H.-J., Jancsik, V, Schleicher, A., Hagemann, G., Witte, O. W., Woodhams, P., & Zilles, K. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00289-3 · Cited by 74 · see citing works
Cross, A. K., Haddock, G., Stock, C. J., Allan, S. M., Surr, J., Bunning, R. A. D., Buttle, D. J., & Woodroofe, M. N. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.136 · Cited by 68 · see citing works
Nakagawa, F., Schulte, B. A., Wu, J. Y., & Spicer, S. S. (1986) · Journal of Neurocytology · doi:10.1007/bf01611440 · Cited by 67 · see citing works
Nitzsche, B., Frey, S., Collins, L. D., Seeger, J., Lobsien, D., Dreyer, A., Kirsten, H., Stoffel, M. H., Fonov, V. S., & Boltze, J. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00069 · Cited by 61 · see citing works
Neural ECM in addiction, schizophrenia, and mood disorder
Lubbers, B. R., Smit, A. B., Spijker, S., & van den Oever, M. C. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00012-8 · Cited by 60 · see citing works
Okamoto, M., Mori, S., & Endo, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91217-3 · Cited by 59 · see citing works
Yamada, J., & Jinno, S. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24132 · Cited by 59 · see citing works
Brauer, K., Werner, L., & Leibnitz, L. (1982) · PubMed · Cited by 59 · see citing works
Neural ECM molecules in axonal and synaptic homeostatic plasticity
Frischknecht, R., Chang, K.-J., Rasband, M. N., & Seidenbecher, C. I. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00004-9 · Cited by 53 · see citing works
Suttkus, A., Holzer, M., Morawski, M., & Arendt, T. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.040 · Cited by 50 · see citing works
Caught in the Net: Perineuronal Nets and Addiction
Slaker, M. L., Blacktop, J. M., & Sorg, B. A. (2016) · Neural Plasticity · doi:10.1155/2016/7538208 · Cited by 50 · see citing works
Härtig, W. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00179-2 · Cited by 46 · see citing works
Self-citationKaretko-Sysa, M., Skangiel-Kramska, J., & Nowicka, D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.022 · Cited by 45 · see citing works
Chen, X.-R., Liao, S.-J., Ye, L.-X., Gong, Q., Ding, Q., Zeng, J.-S., & Yu, J. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.002 · Cited by 43 · see citing works
Extracellular matrix modulation is driven by experience-dependent plasticity during stroke recovery.
Quattromani, M. J., Pruvost, M., Guerreiro, C., Backlund, F., Englund, E., Aspberg, A., Jaworski, T., Hakon, J., Ruscher, K., Kaczmarek, L., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0461-2 · Cited by 39 · see citing works
Bistable parvalbumin circuits pivotal for brain plasticity
Hensch, T. K. (2014) · Cell · doi:10.1016/j.cell.2013.12.034 · Cited by 39 · see citing works
Hawkes, C. A., Michalski, D., Anders, R. M., Nissel, S., Grosche, J., Bechmann, I., Carare, R. O., & Härtig, W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.020 · Cited by 39 · see citing works
Self-citationLevy, C., Brooks, J. M., Chen, J., Su, J., & Fox, M. A. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23701 · Cited by 38 · see citing works
Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex
Virgintino, D., Perissinotto, D., Girolamo, F., Mucignat, M. T., Montanini, L., Errede, M., Kaneiwa, T., Yamada, S., Sugahara, K., Roncali, L., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00694.x · Cited by 36 · see citing works
Michalski, D., Härtig, W., Krügel, K., Edwards, R. H., Böddener, M., Böhme, L., Pannicke, T., Reichenbach, A., & Grosche, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.046 · Cited by 30 · see citing works
Self-citationBignami, A., Asher, R., Perides, G., & Rahemtulla, F. G. (1992) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(92)90018-u · Cited by 27 · see citing works
Evolution of the Concept of `Extracellular Matrix' in the Brain
Celio, M. R. (1999) · Journal of the History of the Neurosciences · doi:10.1076/jhin.8.2.186.1832 · Cited by 18 · see citing works
Michalski, D., Preißler, H., Hofmann, S., Kacza, J., & Härtig, W. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.013 · Cited by 17 · see citing works
Self-citationHärtig, W., Appel, S., Suttkus, A., Grosche, J., & Michalski, D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.004 · Cited by 15 · see citing works
Self-citationImplementation of thrombolysis for ischaemic stroke
Dirks, M., & Dippel, D. W. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70304-6 · Cited by 8 · see citing works
Nitzsche, B., Barthel, H., Lobsien, D., Boltze, J., Zeisig, V., & Dreyer, A. Y. (2016) · Neuromethods · doi:10.1007/978-1-4939-3730-1_15 · Cited by 7 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Menzies, 1992, Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model, Neurosurgery, 31, 100, 10.1097/00006123-199207000-00014 · DOI · Paper page
- Morawski, 2010, Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice, Neurobiol. Aging, 31, 1254, 10.1016/j.neurobiolaging.2008.07.023 · DOI
Cited by
Sorted by citations
The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170 · see citing works
- Authors
- Härtig, W., Mages, B., Aleithe, S., Nitzsche, B., Altmann, S., Barthel, H., Krueger, M., & Michalski, D.
- Affiliations
- Leipzig University (DE)
- Corresponding author
- Härtig, Wolfgang
- Venue
- Frontiers in Integrative Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-08-15
- Volume
- 11
- Pages
- 15-15
- ISSN
- 1662-5145 (ISSN-L)
- PMC
- PMC5559442
- OpenAlex
- W2748143122
- Cited by
- 53
- References
- 94
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 7 · 2020: 10 · 2019: 3 · 2018: 8
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Integrative Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, cc-by)
- Funders
- European Social Fund (100270131)
- Deutsche Forschungsgemeinschaft (BA 3425/2-3)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- perineuronal nets, focal cerebral ischemia, ischemic stroke, neurovascular unit, extracellular matrix, chondroitin sulfate proteoglycans, type IV collagen, astroglial activation, parvalbumin, GABAergic neurons, aggrecan, neurocan, versican, middle cerebral artery occlusion, stroke model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review